Celecoxib does not affect the release of hyaluronic acid in end stage osteoarthritic joints

REFERENCES

• Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt 103, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthr Cartil. 2007;15: 981–1000.
   Google Scholar
• Mastbergen SC, Jansen NWD, Bijlsma JJW, Lafeber FP. Differential direct effect of cyclo-oxygenase 1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro study. Arthritis Res Ther. 2006;8(R2):1–9.
   Google Scholar
• de Boen TN, Huisman AM, Polak AA, et al. The chondropro-tective effect of selective COX-2 inhibition in osteoarthritis: ex vivo evaluation of human cartilage tissue after in vivo treatment. Osteoarthr Cartil. 2009;17:482–8.
   PubMedGoogle Scholar
• Siegle I, Klein T, Backman JT, Saal JG, Niising RM, Fritz P. Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases. Arthritis Rheum. 1998;41:122–9.
   PubMed Web of Science ®Google Scholar
• Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diag-nostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29:1039–49.
   Google Scholar
• Yamanaka H, Matsuda Y, Tanaka M, Sendo W, Nakajima H, Taniguchi A, Kamatani N. Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis. Arthritis Rheum. 2000;43: 852–8.
   Google Scholar
• Sahap Atik 0. Leukotriene B4 and prostaglandin E2-like activity in synovial fluid in osteoarthritis. Prostaglandins Leukot Essent Fatty Acids. 1990;39:253–4.
   PubMedGoogle Scholar
• Hardy MM, Seibert K, Manning PT, Currie MG, Woerner BM, Edwards D, Koki A, Tripp CS. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants. Arthritis Rheum. 2002;46: 1789–803.
   PubMed Web of Science ®Google Scholar
• Wang CT, Lin YT, Chiang BL, Lin YH, Hou SM. High molec-ular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis. Osteo-arthr Cartil. 2006;14:1237–47.
   Google Scholar
• Elliott AL, Kraus VB, Luta G, Stabler T, Renner JB, Woodard J, Dragomir AD, Helmick CG, Hochberg MC, Jordan JM. Serum hyaluronan levels and radiographic knee and hip osteoarthritis in African Americans and Caucasians in the Johnston County Osteoarthritis Project. Arthritis Rheum. 2005;52:105–11.
   PubMed Web of Science ®Google Scholar
• Pavelka K, Forejtová S, Olejárová M, Gatterová J, Senolt L, Spacek P, Braun M, Hulejová M, Stovicková J, Pavelková A. Hyaluronic acid levels may have predictive value for the pro-gression of knee osteoarthritis. Osteoarthr Cartil. 2004;12:277–83.
   PubMed Web of Science ®Google Scholar
• Sztrolovics R, Recklies AD, Roughley PJ, Mort JS. Hyaluronate degradation as an alternative mechanism for proteoglycan release from cartilage during interleukin- lbeta-stimulated catabolism. Biochem J. 2002;362(2):473–9.
   PubMedGoogle Scholar
• Flannery CR, Hughes CE, Schumacher BL, Tudor D, Aydelotte MB, Kuettner KE, Caterson B. Articular cartilage superficial zone protein (SZP) is homologous to megakaryocyte stimulating factor precursor and Is a multifunctional proteoglycan with potential growth-promoting, cytoprotective, and lubricating properties in cartilage metabolism. Biochem Biophys Res Com-mun. 1999;27:535–41.
   Google Scholar
• Chockalingam PS, Zeng W, Morris EA, Flannery CR. Release of hyaluronan and hyaladherins (aggrecan G1 domain and link proteins) from articular cartilage exposed to ADAMTS-4 (agg-recanase 1) or ADAMTS-5 (aggrecanase 2). Arthritis Rheum. 2004;50:2839–48.
   PubMedGoogle Scholar
• Mastbergen SC, Bijlsma JW, Lafeber FP. Selective COX-2 inhibition is favorable to human early and late-stage osteoarthritic cartilage: a human in vitro study. Osteoarthr Cartil. 2005;13: 519–26.
   Google Scholar
• El Hajjaji H, Marcelis A, Devogelaer JP, Manicourt DH. Cele-coxib has a positive effect on the overall metabolism of hyalu-ronan and proteoglycans in human osteoarthritic cartilage. J Rheumatol. 2003;30:2444–51.
   PubMed Web of Science ®Google Scholar
• Jiang D, Zou J, Huang L, Shi Q, Zhu X, Wang G, Yang H. Efficacy of intra-articular injection of celecoxib in a rabbit model of osteoarthritis. Int J Mol Sci. 2010;21:4106–13.
   Google Scholar
• Alvarez-Soria MA, Largo R, Santillana J. Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cyto-kine profile between celecoxib and aceclofenac. J Ann Rheum Dis. 2006;65: 998–1005.
   Google Scholar